EDN1 and pulmonary arterial hypertension: In PAH, in situ thrombosis may be partially attributed to the persistent rise in local hemodynamic stress, elevated ET-1 levels, inflammatory mediators, and certain growth factors, along with a loss of NO and vasoprotective prostacyclin [87,88].